NCT03538002 is a NA clinical trial of Blue-light filtering spectacle lenses in Myopia, sponsored by The Hong Kong Polytechnic University.

Who is sponsoring NCT03538002?

NCT03538002 is sponsored by The Hong Kong Polytechnic University.

What drugs are being tested in NCT03538002?

Interventions in NCT03538002: Blue-light filtering spectacle lenses.

Is NCT03538002 still recruiting?

NCT03538002 is currently completed. Last updated 13 January 2022.

Last reviewed 2022-01-13 · How we verify

NCT03538002

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

The Effect of Blue-light Filtering Spectacle Lenses on Myopia Progression in Schoolchildren

Completed NA Last updated 13 January 2022

What this trial tests

NA trial testing Blue-light filtering spectacle lenses in Myopia in 148 participants. Completed in 30 November 2021.

Timeline

10 September 2018

Primary endpoint
30 November 2021

30 November 2021

Quick facts

Lead sponsor	The Hong Kong Polytechnic University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	treatment
Enrollment	148
Start date	10 September 2018
Primary completion	30 November 2021
Estimated completion	30 November 2021
Sites	1 location across Hong Kong

Drugs / interventions tested

Blue-light filtering spectacle lenses

Conditions studied

Myopia — all drugs for Myopia →

Sponsor

The Hong Kong Polytechnic University

Who can join

Adults 8 to 13, any sex, with Myopia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to investigate if the blue-light filtering spectacle lenses promote myopia progression in schoolchildren.

Publications & conference data

4 peer-reviewed publications reference this trial (live from Europe PMC):

Interventions to slow progression of myopia in children.
Walline JJ, Lindsley KB, Vedula SS, Cotter SA, et al · · 2020 · cited 128× · PMID 31930781 · DOI 10.1002/14651858.cd004916.pub4
Interventions for myopia control in children: a living systematic review and network meta-analysis.
Lawrenson JG, Shah R, Huntjens B, Downie LE, et al · · 2023 · cited 117× · PMID 36809645 · DOI 10.1002/14651858.cd014758.pub2
IMI 2021 Yearly Digest.
Jong M, Jonas JB, Wolffsohn JS, Berntsen DA, et al · · 2021 · cited 59× · PMID 33909031 · DOI 10.1167/iovs.62.5.7
Evaluation of an Optical Defocus Treatment for Myopia Progression Among Schoolchildren During the COVID-19 Pandemic.
Choi KY, Chun RKM, Tang WC, To CH, et al · · 2022 · cited 26× · PMID 35029662 · DOI 10.1001/jamanetworkopen.2021.43781

Verify or expand the search:

Other recruiting trials for Myopia

Currently open trials in the same condition.

NCT07284966 — Comfort and Vision With TOTAL30 Multifocal Lenses · recruiting
NCT07078799 — Wavefront-guided LASIK Surgery Compared to Ray Tracing-Guided LASIK Surgery · NA · recruiting
NCT07585877 — Effect of Branched-Chain Amino Acid Supplementation on Myopia Progression · NA · active not recruiting
NCT07354945 — An Evaluation of Myopia Control Lenses on Wearing Experience in Myopic Children · NA · recruiting
NCT07229365 — Children's Viewing Behavior · NA · recruiting

Other The Hong Kong Polytechnic University trials

Trials by the same sponsor.

NCT07505732 — Information-providing Chatbot · NA · not yet recruiting
NCT07391449 — Heart Rate Variability Guided Physical Activity and Exercise Prescription in Individuals With Knee Osteoarthritis · NA · not yet recruiting
NCT07450248 — The Use of Telephone-based ACT for Quitting Alcohol in the Young Population With Hazardous or Harmful Alcohol Use. · NA · not yet recruiting
NCT07273682 — Nurse-led Transitional Care to Improve Symptom Management in Childhood Cancer Survivors · NA · not yet recruiting
NCT07531082 — Effects of a Salutogenic Strength-based Social Robot-assisted Intervention on the Depressive Symptoms and Sense of Coher · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03538002 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by The Hong Kong Polytechnic University
Last refreshed: 13 January 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03538002.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing